登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：002332 证券简称：仙琚制药 公告编号：2025-030 浙江仙琚制药股份有限公司 关于注销参股公司暨关联交易的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误导性陈述或重大遗 漏。 浙江仙琚制药股份有限公司（以下简称"公司"）于2025年8月10日以通讯方式召开第八届董事会第十五 次会议、第八届监事会第十次会议，审议通过了《关于注销参股公司暨关联交易的议案》，同意注销参 股公司仙居县聚合金融服务有限公司（以下简称 "聚合金融"）。 聚合金融于2016年6月设立，当时根据地方政府相关精神，为促进地方经济发展，由地方总商会牵头， 公司与控股股东仙居县产业投资发展集团有限公司等股东共同出资设立，公司出资1000万元持有其20% 的股权。 《关于注销参股公司暨关联交易的议案》已经公司独立董事专门会议审议通过。关联董事陈卫武先生、 曹保湖先生、关联监事李燕琴女士均已回避表决。 根据《中华人民共和国公司法》《公司章程》《关联交易管理制度》等规定，本次注销参股公司暨关联 交易事项在公司董事会决策权限内，无需提交公司股东大会审议 ...

Core Points - The company held its 15th meeting of the 8th Board of Directors on August 10, 2025, with all 9 directors present [1] - The board unanimously approved the proposal to dissolve a subsidiary and related transactions, with 7 votes in favor and no abstentions or oppositions [1] - Related directors Chen Weiwu and Cao Baohu abstained from voting on the proposal [1] Summary by Sections - **Meeting Details** - The meeting was convened by Chairman Zhang Yusong and complied with relevant laws and company regulations [1] - Notification of the meeting was sent via email on August 4, 2025 [1] - **Decisions Made** - The board approved the proposal regarding the dissolution of a subsidiary and related transactions [1] - The announcement regarding the dissolution will be published in various financial newspapers and on the official website [1]

Core Viewpoint - The company has decided to dissolve a joint venture based on its own development and management considerations, ensuring compliance with relevant laws and regulations [1][2]. Group 1 - The eighth supervisory board meeting was held on August 10, 2025, with all seven supervisors participating, and the decision to dissolve the joint venture was passed with six votes in favor [1]. - The decision to dissolve the joint venture was made without harming the interests of the company and all shareholders, particularly minority shareholders [2]. - The related director recused themselves from the voting process to ensure compliance with legal and procedural requirements [2].

Core Viewpoint - The company has decided to liquidate its subsidiary, Xianju County Juhua Financial Services Co., Ltd., due to a lack of business activity and changes in financial policies, which aligns with its development needs and does not harm the interests of shareholders [1][8]. Summary by Sections Company Decision - The company held a board meeting on August 10, 2025, where it approved the proposal to liquidate the subsidiary [1]. - The decision was made following the review by independent directors, ensuring compliance with relevant laws and regulations [8]. Subsidiary Information - Xianju County Juhua Financial Services Co., Ltd. was established in June 2016 with a registered capital of 50 million yuan, in which the company held a 20% stake [1]. - The subsidiary's main business, providing loan turnover services for small and medium-sized enterprises, has ceased operations [8]. Financial Data of the Subsidiary - As of December 31, 2024, the subsidiary had total assets of approximately 56.51 million yuan and total liabilities of about 4.20 million yuan [1]. - For the first five months of 2025, the subsidiary reported a net profit of approximately 370,273.45 yuan [1]. Impact on the Company - The liquidation will not affect the company's business development or profitability, nor will it harm the interests of shareholders, especially minority shareholders [8]. - The company has not provided any guarantees or financial support to the subsidiary, ensuring no financial risk from this decision [8]. Independent and Supervisory Opinions - The independent directors and the supervisory board have both expressed support for the liquidation, stating that it is in line with the company's development strategy and does not harm shareholder interests [8].

Core Viewpoint - The company has decided to deregister its subsidiary, Yuhe Financial Services Co., Ltd., due to changes in financial regulations that have rendered its original business model unsustainable [2][3]. Group 1: Company Decision - The company announced the decision to deregister Yuhe Financial, in which it holds a 20% stake with an investment of 10 million yuan [1]. - Yuhe Financial was established in June 2016 and primarily served small and medium-sized enterprises in Xianju County [1]. Group 2: Impact of Financial Policy Changes - The original business operations of Yuhe Financial, focused on loan turnover for small and medium enterprises, have ceased due to ongoing adjustments in financial regulatory policies [2]. - Regulatory authorities have mandated that Yuhe Financial either change its business scope or cease operations, leading to the decision for dissolution and liquidation [2]. Group 3: Operational Independence - The company clarified that it has not provided any guarantees, financial support, or entrusted financial services to Yuhe Financial, indicating a low level of operational interdependence [4]. - The deregistration will not affect the company's main business operations, which focus on the research, production, and sales of steroid raw materials and formulations across four major categories: corticosteroids, sex hormones, anesthetics, and respiratory drugs [4]. - The deregistration process does not involve any personnel placement issues and will not impact the company's ongoing profitability [4].

Group 1 - The company Xianju Pharmaceutical announced on August 10 that its eighth board meeting was held via communication method on the same day [1] - The board reviewed the proposal regarding the cancellation of a subsidiary company and related transactions [1]

浙江仙琚制药股份有限公司（以下简称"公司"）于 2025 年 8 月 10 日以通讯方式召 开第八届董事会第十五次会议、第八届监事会第十次会议，审议通过了《关于注销参股公 司暨关联交易的议案》，同意注销参股公司仙居县聚合金融服务有限公司（以下简称 "聚 合金融"）。 聚合金融于 2016 年 6 月设立，当时根据地方政府相关精神，为促进地方经济发展，由 地方总商会牵头，公司与控股股东仙居县产业投资发展集团有限公司等股东共同出资设立， 公司出资 1000 万元持有其 20%的股权。 《关于注销参股公司暨关联交易的议案》已经公司独立董事专门会议审议通过。关联 董事陈卫武先生、曹保湖先生、关联监事李燕琴女士均已回避表决。 根据《中华人民共和国公司法》《公司章程》《关联交易管理制度》等规定，本次注 销参股公司暨关联交易事项在公司董事会决策权限内，无需提交公司股东大会审议。现将 具体情况公告如下： 证券代码：002332 证券简称：仙琚制药 公告编号：2025-030 浙江仙琚制药股份有限公司 关于注销参股公司暨关联交易的公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚假记载、误 导性陈述或重大遗 ...

会议以 6 票同意，0 票弃权，0 票反对，审议通过了《关于注销参股公司暨 关联交易的议案》。关联监事李燕琴女士回避表决。 经审核，监事会认为：公司本次注销合资公司是基于公司自身发展和经营管 理角度考虑做出的决策，符合相关法律法规、规范性文件及《公司章程》的规定， 本次关联交易不存在损害公司及全体股东，特别是中小股东利益的情形。公司董 事会表决时关联董事已进行回避，审议和决策程序合法合规。因此，我们同意本 次注销参股公司暨关联交易事项。 《关于注销参股公司暨关联交易的公告》详见 2025 年 8 月 11 日的《证券时 报 》、《 中 国 证 券 报 》、《 上 海 证 券 报 》、《 证 券 日 报 》 和 巨 潮 资 讯 网 （www.cninfo.com.cn）。 特此公告。 证券代码：002332 证券简称：仙琚制药 公告编号：2025-032 浙江仙琚制药股份有限公司 第八届监事会第十次会议决议公告 本公司及监事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 浙江仙琚制药股份有限公司（以下简称"公司"）第八届监事会第十次会议 通知已于 2025 年 8 月 4 ...

会议以 7 票同意，0 票弃权，0 票反对，审议通过了《关于注销参股公司暨 关联交易的议案》。关联董事陈卫武先生、曹保湖先生回避表决。 董事会 浙江仙琚制药股份有限公司 第八届董事会第十五次会议决议公告 本公司及董事会全体成员保证信息披露内容的真实、准确和完整，没有虚 假记载、误导性陈述或重大遗漏。 《关于注销参股公司暨关联交易的公告》详见 2025 年 8 月 11 日的《证券时 报 》、《 中 国 证 券 报 》、《 上 海 证 券 报 》、《 证 券 日 报 》 和 巨 潮 资 讯 网 （www.cninfo.com.cn）。 证券代码：002332 证券简称：仙琚制药 公告编号：2025-031 特此公告。 浙江仙琚制药股份有限公司 浙江仙琚制药股份有限公司（以下简称"公司"）第八届董事会第十五次会 议通知已于 2025 年 8 月 4 日以电子邮件方式向公司全体董事发出，会议于 2025 年 8 月 10 日以通讯方式召开。本次会议应参加董事 9 名，实际参加董事 9 名， 会议由公司董事长张宇松先生召集并主持。本次会议的召集、召开符合《中华人 民共和国公司法》和《公司章程》的有关规定。全体与会董事 ...

| 002356 | 赫美集 | 1.26 | 1.76 | 3.20 | 3.22 | 0.72 | | --- | --- | --- | --- | --- | --- | --- | | | 团 | | | | | | | 002813 | 路畅科 | 1.45 | 4.69 | 24.37 | 24.54 | 0.72 | | | 技 | | | | | | | 002150 | 通润装 | 1.54 | 3.86 | 12.47 | 12.55 | 0.64 | | | 备 | | | | | | | 002332 | 仙琚制 | 1.07 | 2.85 | 10.34 | 10.41 | 0.64 | | | 药 | | | | | | | 000875 | 吉电股 | 1.74 | 1.57 | 5.24 | 5.27 | 0.63 | | | 份 | | | | | | | 688276 | 百克生 | 2.69 | 1.71 | 23.88 | 24.03 | 0.61 | | | 物 | | | | | | | 601158 | 重庆水 | 0.64 | 0.20 | 4.70 | 4. ...